|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$2.48 |
$2.49 |
$2.32 |
$2.33 |
2.08M | 03/25/2024 |
$2.33 |
$2.40 |
$2.26 |
$2.28 |
1.92M | 03/26/2024 |
$2.32 |
$2.39 |
$2.29 |
$2.30 |
4.94M | 03/27/2024 |
$2.32 |
$2.44 |
$2.28 |
$2.42 |
2.58M | 03/28/2024 |
$2.42 |
$2.51 |
$2.36 |
$2.39 |
2.09M |
|
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product. | |
|
Coherus BioSciences (CHRS) has the following price history information. Looking back at CHRS historical stock prices for the last five trading days, on March 22, 2024, CHRS opened at $2.48, traded as high as $2.49 and as low as $2.32, and closed at $2.33. Trading volume was a total of 2.08M shares. On March 25, 2024, CHRS opened at $2.33, traded as high as $2.40 and as low as $2.26, and closed at $2.28. Trading volume was a total of 1.92M shares. On March 26, 2024, CHRS opened at $2.32, traded as high as $2.39 and as low as $2.29, and closed at $2.30. Trading volume was a total of 4.94M shares. On March 27, 2024, CHRS opened at $2.32, traded as high as $2.44 and as low as $2.28, and closed at $2.42. Trading volume was a total of 2.58M shares. On March 28, 2024, CHRS opened at $2.42, traded as high as $2.51 and as low as $2.36, and closed at $2.39. Trading volume was a total of 2.09M shares.
CHRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Coherus BioSciences shares, starting with a $10,000 purchase of CHRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/21/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$13.05 |
|
End price/share: |
$2.39 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-81.69% |
|
Average Annual Total Return: |
-16.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,830.76 |
|
Years: |
9.35 |
|
|
|
Date |
Close |
03/22/2024 | $2.33 | 03/25/2024 | $2.28 | 03/26/2024 | $2.30 | 03/27/2024 | $2.42 | 03/28/2024 | $2.39 |
|
|